Volume 23, Number 11—November 2017
Detection of Spotted Fever Group Rickettsia DNA by Deep Sequencing
Highlight and copy the desired format.
|EID||Graham R, Donohue S, McMahon J, Jennison AV. Detection of Spotted Fever Group Rickettsia DNA by Deep Sequencing. Emerg Infect Dis. 2017;23(11):1911-1913. https://dx.doi.org/10.3201/eid2311.170474|
|AMA||Graham R, Donohue S, McMahon J, et al. Detection of Spotted Fever Group Rickettsia DNA by Deep Sequencing. Emerging Infectious Diseases. 2017;23(11):1911-1913. doi:10.3201/eid2311.170474.|
|APA||Graham, R., Donohue, S., McMahon, J., & Jennison, A. V. (2017). Detection of Spotted Fever Group Rickettsia DNA by Deep Sequencing. Emerging Infectious Diseases, 23(11), 1911-1913. https://dx.doi.org/10.3201/eid2311.170474.|
After conventional molecular and serologic testing failed to diagnose the cause of illness, deep sequencing identified spotted fever group Rickettsia DNA in a patient’s blood sample. Sequences belonged to R. honei, the causative agent of Flinders Island spotted fever. Next-generation sequencing is proving to be a useful tool for clinical diagnostics.
When conventional laboratory tests cannot identify an etiologic agent, unbiased deep sequencing performed directly on a clinical sample has the potential to identify a probable cause of disease. We used deep sequencing to detect spotted fever group (SFG) Rickettsia DNA in the blood of a patient for whom diagnosis was not possible through conventional molecular and serologic testing.
In late 2016, a middle-aged woman was admitted to a regional hospital in Queensland, Australia, after 2 weeks of mild cough, myalgia, fever, and lethargy. The day before admission, she experienced a blanching rash and pains in her feet, after which her condition deteriorated and a definite petechial rash appeared. Chest radiographs showed atelectasis on 1 side. Meningococcal septicemia was suspected, and the patient was transferred to intensive care with septic shock. Despite treatment with inotropes and several antimicrobial drugs (including ceftriaxone, vancomycin, meropenem, doxycycline), the patient died the next morning.
Clinical testing did not identify an infectious disease agent in the patient’s blood; serologic test results for Rickettsia were negative. Because a limited amount of specimen remained for testing, we applied an unbiased deep-sequencing approach. We extracted DNA from the blood sample by using the MasterPure Complete DNA Purification Kit (Epicenter, Madison, WI, USA) and sequenced with the Ion Torrent PGM (Personal Genome Machine) workflow by using the Ion PGM IC 200 Kit and the Ion 316 Chip Kit, version 2 (Life Technologies, Carlsbad, CA, USA). A total of 3,627,903 sequences were generated and trimmed by using a minimum quality score of Q15 and minimum length of 50 bp. Of the reads generated, 251 matched bacterial DNA sequences (uploaded to GenBank as Bioproject PRJEB21107). The rest either matched human genome sequences and were filtered out (3,619,386 reads) or were unclassified (8,252 reads).
We analyzed the reads for bacterial DNA by using 3 metagenomics tools: Kraken (1), PathoScope (2), and One Codex (https://www.onecodex.com). All 3 analyses returned similar results; ≈80% of classified reads (208/251 reads, 53,958 total nucleotides) matched sequences from SFG Rickettsia spp.; the remainder gave low-number, low-quality matches to other bacteria. Screening of reads for sequences matching 5 rickettsial genes (rrs, ompA, ompB, gltA, and sca4) found 1 read mapping to the ompB gene (Technical Appendix [PDF - 458 KB - 17 pages]). This read was a 100% match (272/272 nt) to R. honei ompB (GenBank accession nos. AF123724.1, AF123711.1). The next highest match was to R. parkerii ompB (accession no. KY113111.1) at 99% (270/272 nt). We confirmed the presence of SFG Rickettsia DNA in the DNA extract of the sample by nested PCR and performed Sanger sequencing by using the Invitrogen SuperScript III One-Step RT-PCR system with primers (3) and in-house nested primers.
To narrow down the identification to species level, we further analyzed sequences matching Rickettsia spp. We downloaded all Rickettsia genomes available at the National Center for Biotechnology Information (https://www.ncbi.nlm.nih.gov/), complete and draft, and used them as reference sequences for mapping of the reads in CLC Genomics Workbench 8 (QIAGEN Aarhus, Silkeborgvej, Denmark). We discarded reads mapping to >1 genome, collected the remaining reads that mapped uniquely to a single genome, and noted the genome to which they mapped. Of the 208 reads, 67 mapped to >1 genome, 1 did not map to any of the genomes and was subsequently identified as matching that of the human reference genome, 3 were unique matches to R. conorii (AJUR01, GenBank accession no. NC_003103), 1 was a unique match to R. sibirica (accession no. NZ_AHZB01000018), and 151 were unique matches to R. honei (accession no. NZ_AJTT00000000) (Technical Appendix [PDF - 458 KB - 17 pages]) (4). Mapping of the 208 sequencing reads revealed that 207 (99.6%) reads mapped to the R. honei genome, giving 1.43% coverage of the genome, and 168 (80.7%) reads mapped to the R. australis (accession no. NC_017058) genome, representing 0.03% coverage of the genome.
The main causes of SFG rickettsioses in Australia are R. australis and R. honei, which cause Queensland tick typhus and Flinders Island spotted fever, respectively (5). The rickettsial DNA in the blood sample we describe most closely matched sequences from R. honei and had a relatively low level of similarity to sequences from R. australis. R. honei was initially reported only in the southern states of Australia; however, a genetic variant known as the “marmionii” strain has since been reported in eastern and northern parts of the country (6). Unfortunately, the genome of R. honei “marmionii” has not been sequenced, and the genes used to differentiate between R. honei and R. honei “marmionii” were not covered by the sequences generated from the sample. Therefore, we could not confirm which strain of R. honei was in the sample.
Flinders Island spotted fever is reportedly associated with relatively mild illness (5). However, our detection of R. honei DNA in the blood of a deceased patient, in the absence of positive Rickettsia serologic test results, is suggestive of acute infection with this agent. This case demonstrates the potential of deep sequencing for identifying unknown etiologic agents, particularly when other methods have not done so.
Dr. Graham is a senior scientist in the Molecular Epidemiology Unit of the Queensland Department of Health Public Health Microbiology Laboratory at Forensic and Scientific Services. Her work involves research into the potential of whole-genome sequencing as a tool for public health microbiology.
We thank the Townsville Public Health Unit of Pathology Queensland and the Public Health Virology Laboratory at Queensland Health Forensic and Scientific Services for performing routine testing.
- Wood DE, Salzberg SL. Kraken: ultrafast metagenomic sequence classification using exact alignments. Genome Biol. 2014;15:R46.
- Hong C, Manimaran S, Shen Y, Perez-Rogers JF, Byrd AL, Castro-Nallar E, et al. PathoScope 2.0: a complete computational framework for strain identification in environmental or clinical sequencing samples. Microbiome. 2014;2:33.
- Webb L, Carl M, Malloy DC, Dasch GA, Azad AF. Detection of murine typhus infection in fleas by using the polymerase chain reaction. J Clin Microbiol. 1990;28:530–4.
- Xin D, El Karkouri K, Robert C, Raoult D, Fournier P-E. Genomic comparison of Rickettsia honei strain RBT and other Rickettsia Species. J Bacteriol. 2012;194:4145.
- Graves S, Stenos J. Rickettsioses in Australia. Ann N Y Acad Sci. 2009;1166:151–5.
- Unsworth NB, Stenos J, Graves SR, Faa AG, Cox GE, Dyer JR, et al. Flinders Island spotted fever rickettsioses caused by “marmionii” strain of Rickettsia honei, Eastern Australia. Emerg Infect Dis. 2007;13:566–73.
Technical AppendixCite This Article
- Page created: October 17, 2017
- Page last updated: October 17, 2017
- Page last reviewed: October 17, 2017
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)